Patient centric sales
How a holistic approach requires a paradigm shift from pharma sales
30th August 2018
Web Exclusives
Choosing the right non-clinical CRO
When faced with a dizzying array of CROs of different profiles, sizes and locations, how do sponsors know who to trust?
30th August 2018
The intelligent supply chain
How an intelligent pharmaceutical supply chain enhances patient-caregiver experience
29th August 2018
Why companies should bring biosimilar studies to the UK
There is still much to do to realise the full cost saving benefits of biosimilars, and much of this boils down to clinical confidence
20th August 2018
A new era in the management of HIV
A growing body of evidence suggests that two-drug regimens could be hugely important for HIV patients
17th August 2018
Pharma M&A booms in H1 2018
Patient-centricity, biotech and new data tech have all characterised a record H1 for pharma deals
15th August 2018
How new tech is changing Alzheimer's treatment
CRISPR could help turn Alzhimer's findings into a cure, but there are several barriers to overcome first
13th August 2018
The current landscape for Alzheimer’s drugs
An overview of the latest drug developments in this notoriously-difficult disease area
9th August 2018
Why biosimilars won’t be the only shake up in biologics
The potential for oral delivery could completely change the landscape for biologics
8th August 2018
Digital transformation in life sciences R&D: breaking down barriers
Unclear ambitions and disjointed initiatives are threatening pharmaceutical companies’ ROI from advanced technologies
7th August 2018
Why is there a struggle with linguistic validation?
Ensuring clinical outcome assessment-measures are culturally relevant as well as accurately translated for each target market
3rd August 2018
The Wisdom of Ignorance
Three things consumers can learn from the world of healthcare, and three things healthcare can learn from consumers.
3rd August 2018
Exploring validation and data integrity in pharma
What pharma companies need to know about this important area
3rd August 2018
Patents in the pharma sector – recent developments
What the current patent litigation landscape looks like for pharma now and beyond Brexit
1st August 2018
